10 June 2015
Anti-rejection medications for transplant recipients protect against Alzheimer’s disease
A new study from The University of Texas Medical Branch at Galveston has revealed that a treatment taken daily by people who have had organ transplants to prevent organ rejection protects against Alzheimer’s disease. An early online version of this paper detailing the findings has been published and is scheduled for publication in the July 7 issue of the Journal of Alzheimer’s Disease.
25 May 2015
Dementia found to decrease sexual activity
In a new study published in the Journal of Alzheimer’s Disease, Dr Rebekah Ahmed and colleagues found that patients with dementia show a decrease in sexual relations with their partners. The study, led by NeuRA’s Prof John Hodges focused specifically on patients with frontotemporal dementia, the second most common cause of young-onset dementia (aged less than 65 years), which is typically associated with changes in behaviour and personality.
5 May 2015
Green Tea Extract and Exercise Hinder Progress of Alzheimer's Disease in Mice
According to the National Institutes of Health (NIH), Alzheimer’s disease (AD) may affect as many as 5.5 million Americans. Scientists currently are seeking treatments and therapies found in common foods that will help stave off the disease or prevent it completely. Now, University of Missouri researchers have determined that a compound found in green tea, and voluntary exercise, slows the progression of the disease in mice and may reverse its effects.
9 April 2015
Waterford researchers find link between Alzheimer’s disease and impaired vision arising from nutrient deficiency
A team from the Vision Research Centre at Waterford Institute of Technology has discovered that patients with Alzheimer’s disease have significantly worse vision than others in their age group and are more likely to be seriously deficient in carotenoids, key nutrients in the eye. Providing an exciting basis for further research, the multidisciplinary Waterford study also shows that it is possible to improve the vision of patients with Alzheimer’s disease by providing supplements that include the macular pigment they have a deficiency in.
30 March 2015
York U Alzheimer’s study on women at risk suggests functional decline relates to deteriorating brain wiring
A video game-like tool developed from the touchscreen thinking and moving task used in the current study may be the next step in helping to improve communication between brain regions.
In their latest brain imaging study on women at risk for Alzheimer’s disease, York University researchers have found deterioration in the pathways that serve to communicate signals between different brain regions needed for performing everyday activities such as driving a car or using a computer.
30 March 2015
Severe Alzheimer's Patient Responds to Bryostatin Treatment
Researchers at the Blanchette Rockefeller Neurosciences Institute and the Marshall University Joan C. Edwards School of Medicine announced their findings from a new study entitled, "PSEN1 Variant in a Family with Atypical AD." An Alzheimer patient with very severe disease, genetically confirmed to have a known variant of PSEN1, showed promising benefits during treatment with the drug Bryostatin 1.
10 March 2015
Surprising finding provides more support for Alzheimer’s being an autoimmune disease
Brain levels of the lipid ceramide are high in Alzheimer’s disease, and now scientists have found increased levels of an antibody to the lipid in their disease model. While some members of this lipid family are a plus in skin cream, inside the brain, ceramide appears to increase beta amyloid production and help the iconic plaque kill brain cells in Alzheimer’s, said Dr. Erhard Bieberich, neuroscientist at the Medical College of Georgia at Georgia Regents University.
2 February 2015
Decreases in Short-Term Memory, IQ, and Altered Brain Metabolic Ratios in Urban Apolipoprotein ε4 Children Exposed to Air Pollution
A new study heightens concerns over the detrimental impact of the APOE ε4 allele, the most prevalent genetic risk for Alzheimer’s disease, upon cognition, olfaction, and metabolic brain indices in healthy urban children and teens.
2 February 2015
New study postulates the role of dietary advanced glycation end products in the risk of Alzheimer's disease
Our new paper published in the Journal of Alzheimer's Disease provides evidence that cooking foods at high temperatures increases the risk of Alzheimer's disease. This study looked at the content of advanced glycation end products (AGEs) in national diets and clinical studies comparing and compared total AGEs to Alzheimer's disease rates.
20 January 2015
First Evidence of Potential Efficacy of Tau Aggregation Inhibitor Therapy in Alzheimer’s Disease
The results of a Phase II clinical trial of a Tau Aggregation Inhibitor (TAI) in AD, conducted by TauRx Therapeutics Ltd (a Singapore incorporated spinout from the University of Aberdeen), provided the basis and rationale for subsequent Phase III clinical trials of a TAI in AD currently in progress.